caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1710961404

Pam SholarMD

Hematology-OncologyStatesville, NCI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Pam Sholar's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 48 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
IREDELL MEMORIAL HOSPITAL, INCORPORATED3984,583
NORTH CAROLINA BAPTIST HOSPITAL3335,404
Thomas Gaston
Diagnostic Radiology · Statesville, NC
2041,287
Ahmed Elnaggar
Pulmonary Disease · Statesville, NC
55362
Jose Perez
Pulmonary Disease · Statesville, NC
46417
Debra Harr
Radiation Oncology · Clayton, NC
46641
STATESVILLE HMA LLC43221
GRIMM, RUBY39218
RUBY ANN GRIMM33119
Raj Joshi
Internal Medicine · Statesville, NC
32304
Ray Georgeson
Cardiology · Statesville, NC
30205
Piedmont Pathology Associates Inc
Clinical Laboratory · Hickory, NC
2992
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
812
Unique beneficiaries
—
Total services
42,930
Distinct HCPCS
20
Medicare payment
$183K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 329 Hematology-Oncology providers in NC — top quintile (cohort median 605).
PRESCRIBING · PART D · 2024
Total Rx claims
1,474
Beneficiaries
—
Total drug cost
$2.2M
Distinct drugs
45
Brand share
24.7%
Top prescribed drugs
Apixaban145 claims
Letrozole143 claims
Potassium Chloride111 claims
Ondansetron Hcl72 claims
Prednisone61 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.